Stay updated on Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.

Latest updates to the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page
- Check2 days agoChange DetectedThe Participating Locations section has been updated to reflect changes in sites across multiple states and countries. This may affect where patients can enroll and access trial information.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check31 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference2%

- Check38 days agoChange DetectedAdded version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several core safety sections. If these deletions are intended, this is a major reduction in detailed drug-safety content.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision updated to v3.0.2; removed 'Back to Top' element.SummaryDifference0.1%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%

- Check67 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional publications related to ensifentrine and its effects on chronic obstructive pulmonary disease (COPD). Notably, the revision version has changed from v2.16.12 to v3.0.0.SummaryDifference10%

Stay in the know with updates to Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.